Most recent articles by:

Peter

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.
- Advertisement -spot_img

Europe’s Proposed New ‘Safe’ Levels Of THC In Hemp & CBD Products Are ‘Unacceptable’ and ‘Unnecessarily’ Low

NEWLY-proposed 'safety' levels of THC in European hemp and CBD food products have been condemned as ‘unacceptable, unnecessarily low, and not supported by scientific...

Zurich Seeks Cannabis Club Volunteers And Swiss Business To Support Its Adult-Use Trial

SWITZERLAND’S largest city Zurich has unveiled details of its adult-use recreational trial which is set to begin in Autumn next year. Entitled ‘Züri Can -...

New Medical Director Appointed At UK Cannabis Company AltoVerde

MULTIFACETED cannabis company AltoVerde has announced the appointment of Dr Kuldip Birdi as its new Medical Director.  Dr Kuldip Birdi will help develop AltoVerde’s medical...

Healthy Demand For Guernsey’s First Medical Cannabis Cultivation Licences With Applicants Bullish On Prospects

GUERNSEY cannabis company The House of Green has submitted three of the seven medical cannabis production applications in the UK Crown Dependencies’ first licensing...

Ambitious Plans To Deliver A 100-Fold Increase In UK Hemp Cultivation Gets Government Backing

TAXPAYERS cash support for the emerging UK hemp industry has been welcomed as a further sign the Government is waking-up to the economic and...

Always Pure Organics Looks To The Far East With The Opening Of A New Base in Japan

LEADING UK cannabis business Always Pure Organics (APO) has opened a new division in Japan in a move it believes will help double annual...

KanaVape2.0 Set To Launch – But How Will It Perform In The Commercial Stakes Following Its Stellar Legal Success?

THE world-famous vaping product which changed the legal landscape for European CBD is set for a relaunch. Last November, six years after its unspectacular French...

Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025

COMBINED sales of the three most lucrative cannabis pharmaceuticals products - Epidiolex, Dronabinol and Sativex - are set to reach €1.8 billion by 2025,...

Must read

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior...
- Advertisement -spot_img